MarketWatch.com - Top Stories

Moderna’s wider-than-expected loss and soft guidance weigh on battered stock

COVID-19 vaccine sales topped consensus but RSV sales remain modest

Feb 14, 2025 - 12:40
 0
Moderna’s wider-than-expected loss and soft guidance weigh on battered stock
COVID-19 vaccine sales topped consensus but RSV sales remain modest
Read More

Tags:

Previous Article

Mexico’s President Sheinbaum said her government would ask Google to make ‘Mexic...

Next Article

DXY: Lacks steady upward momentum – Societe Generale

Related Posts

Warren Buffet bought booze, pizza and pool stocks in the fourth quarter, while ditching Ulta Beauty

Warren Buffet bought booze, pizza and pool stocks in th...

Feb 14, 2025  0

Trump’s steel and aluminum tariffs aren’t rattling markets Monday. Blame investor fatigue.

Trump’s steel and aluminum tariffs aren’t rattling mark...

Feb 10, 2025  0

My husband has millions in a trust fund, pays all our bills and gives me $4,000 a month. Will I get our house if I divorce him?

My husband has millions in a trust fund, pays all our b...

Feb 10, 2025  0